SEELOS THERAPEUTICS INC (SEEL) Forecast, Price Target & Analyst Ratings

NASDAQ:SEEL • US81577F3073

Current stock price

1.28 USD
-1.17 (-47.76%)
At close:
1.45 USD
+0.17 (+13.28%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SEELOS THERAPEUTICS INC (SEEL).

Forecast Snapshot

Consensus Price Target

Price Target
$122.40
+ 9,462.50% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Nov 12, 2024
Period
Q3 / 2024
EPS Estimate
-$1.30
Revenue Estimate
76.5K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$122.40
Upside
+ 9,462.50%
From current price of $1.28 to mean target of $122.40, Based on 7 analyst forecasts
Low
$121.20
Median
$122.40
High
$126.00

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for SEEL. The average price target is 122.4 USD. This implies a price increase of 9462.5% is expected in the next year compared to the current price of 1.28.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SEEL Current Analyst RatingSEEL Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

SEEL Historical Analyst RatingsSEEL Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
SEEL was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SEEL.
In the previous month the buy percentage consensus was at a similar level.
SEEL was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-09-22GuggenheimDowngrade Buy -> Neutral
2023-09-21Cantor FitzgeraldDowngrade Overweight -> Neutral
2023-09-21GuggenheimDowngrade Buy -> Neutral
2023-09-21BenchmarkMaintains Speculative Buy -> Speculative Buy
2023-08-22Cantor FitzgeraldReiterate Overweight -> Overweight
2023-08-15Cantor FitzgeraldReiterate Overweight -> Overweight
2023-06-23Cantor FitzgeraldReiterate Overweight -> Overweight
2023-06-23BenchmarkReiterate Speculative Buy -> Speculative Buy
2023-05-16Cantor FitzgeraldMaintains Overweight -> Overweight
2023-05-15BTIGMaintains Buy -> Buy
2023-03-24BenchmarkMaintains Buy
2021-09-27Roth CapitalUpgrade Neutral -> Buy
2021-08-10Roth CapitalMaintains Neutral
2021-07-01GuggenheimInitiate Buy
2021-06-01Cantor FitzgeraldInitiate Overweight
2021-03-30B. Riley FBRInitiate Buy
2021-03-12BTIGInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Nov 12, 2024
Period
Q3 / 2024
EPS Estimate
-$1.30
Revenue Estimate
76.5K
Revenue Q2Q
-81.34%
EPS Q2Q
95.50%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

SEEL is expected to report earnings on 11/12/2024. The consensus EPS estimate for the next earnings is -1.3 USD and the consensus revenue estimate is 76.50K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
SEEL revenue by date.SEEL revenue by date.
2.203M306K
-86.11%		28.968M
9,366.67%		206.96M
614.44%		258.92M
25.11%		370.24M
42.99%		438.58M
18.46%		502.65M
14.61%
EBITDA
YoY % growth
SEEL ebitda by date.SEEL ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
SEEL ebit by date.SEEL ebit by date.
-61.669M
-228.74%		-70.916M
-14.99%		-40.499M
42.89%		-36.618M
9.58%		-63.546M
-73.54%		-31.824M
49.92%		6.018M
118.91%		73.746M
1,125.42%		123.83M
67.91%		126.28M
1.98%
Operating Margin
SEEL operating margin by date.SEEL operating margin by date.
N/AN/A-1,838.36%-11,966.67%-219.37%-15.38%2.32%19.92%28.23%25.12%
EPS
YoY % growth
SEEL eps by date.SEEL eps by date.
-0.75
-70.45%		-10.83
-1,344.00%		-45.32
-318.47%		-1.34
97.05%		-0.33
75.57%		N/AN/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-1.30
95.50%		-0.66
89.51%
Revenue
Q2Q % growth		76.5K
-81.34%		76.5K
-88.28%
EBITDA
Q2Q % growth		N/AN/A
EBIT
Q2Q % growth		-10.541M
16.36%		-11.817M
-47.51%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SEEL Yearly Revenue VS EstimatesSEEL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2019 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
SEEL Yearly EPS VS EstimatesSEEL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
402.41%
Revenue Next 5 Year
195.91%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SEELOS THERAPEUTICS INC / SEEL Forecast FAQ

What is the average price target for SEELOS THERAPEUTICS INC (SEEL) stock?

7 analysts have analysed SEEL and the average price target is 122.4 USD. This implies a price increase of 9462.5% is expected in the next year compared to the current price of 1.28.

Can you provide the upcoming earnings date for SEELOS THERAPEUTICS INC?

SEELOS THERAPEUTICS INC (SEEL) will report earnings on 2024-11-12, before the market open.

What are the consensus estimates for SEELOS THERAPEUTICS INC (SEEL) next earnings?

The consensus EPS estimate for the next earnings of SEELOS THERAPEUTICS INC (SEEL) is -1.3 USD and the consensus revenue estimate is 76.50K USD.

What is the consensus rating for SEEL stock?

The consensus rating for SEELOS THERAPEUTICS INC (SEEL) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.